Mandom Corporation

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, LRLCY has a market cap of 222.6B. Regarding current trading prices, MDOMF is priced at $16.00, while LRLCY trades at $83.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas LRLCY's P/E ratio is 31.12. In terms of profitability, MDOMF's ROE is +0.03%, compared to LRLCY's ROE of +0.18%. Regarding short-term risk, MDOMF is less volatile compared to LRLCY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check LRLCY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, LRLCF has a market cap of 220B. Regarding current trading prices, MDOMF is priced at $16.00, while LRLCF trades at $413.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas LRLCF's P/E ratio is 30.70. In terms of profitability, MDOMF's ROE is +0.03%, compared to LRLCF's ROE of +0.19%. Regarding short-term risk, MDOMF is less volatile compared to LRLCF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check LRLCF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, UNLYF has a market cap of 126.3B. Regarding current trading prices, MDOMF is priced at $16.00, while UNLYF trades at $57.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas UNLYF's P/E ratio is 19.05. In terms of profitability, MDOMF's ROE is +0.03%, compared to UNLYF's ROE of +0.37%. Regarding short-term risk, MDOMF is less volatile compared to UNLYF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check UNLYF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, RBGLY has a market cap of 39.9B. Regarding current trading prices, MDOMF is priced at $16.00, while RBGLY trades at $12.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas RBGLY's P/E ratio is 9.29. In terms of profitability, MDOMF's ROE is +0.03%, compared to RBGLY's ROE of +0.45%. Regarding short-term risk, MDOMF is less volatile compared to RBGLY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check RBGLY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, RBGPF has a market cap of 38.9B. Regarding current trading prices, MDOMF is priced at $16.00, while RBGPF trades at $60.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas RBGPF's P/E ratio is 9.14. In terms of profitability, MDOMF's ROE is +0.03%, compared to RBGPF's ROE of +0.45%. Regarding short-term risk, MDOMF is less volatile compared to RBGPF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check RBGPF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, HENOY has a market cap of 30.9B. Regarding current trading prices, MDOMF is priced at $16.00, while HENOY trades at $18.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas HENOY's P/E ratio is 12.96. In terms of profitability, MDOMF's ROE is +0.03%, compared to HENOY's ROE of +0.10%. Regarding short-term risk, MDOMF is less volatile compared to HENOY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check HENOY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, HENOF has a market cap of 30.1B. Regarding current trading prices, MDOMF is priced at $16.00, while HENOF trades at $72.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas HENOF's P/E ratio is 12.51. In terms of profitability, MDOMF's ROE is +0.03%, compared to HENOF's ROE of +0.10%. Regarding short-term risk, MDOMF is less volatile compared to HENOF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check HENOF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, HENKY has a market cap of 29.1B. Regarding current trading prices, MDOMF is priced at $16.00, while HENKY trades at $17.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas HENKY's P/E ratio is 12.10. In terms of profitability, MDOMF's ROE is +0.03%, compared to HENKY's ROE of +0.10%. Regarding short-term risk, MDOMF is less volatile compared to HENKY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check HENKY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, HELKF has a market cap of 28.5B. Regarding current trading prices, MDOMF is priced at $16.00, while HELKF trades at $68.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas HELKF's P/E ratio is 11.88. In terms of profitability, MDOMF's ROE is +0.03%, compared to HELKF's ROE of +0.10%. Regarding short-term risk, MDOMF is less volatile compared to HELKF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check HELKF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, ETTYF has a market cap of 18.1B. Regarding current trading prices, MDOMF is priced at $16.00, while ETTYF trades at $26.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas ETTYF's P/E ratio is 13.52. In terms of profitability, MDOMF's ROE is +0.03%, compared to ETTYF's ROE of +0.15%. Regarding short-term risk, MDOMF is less volatile compared to ETTYF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check ETTYF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, BDRFY has a market cap of 17.9B. Regarding current trading prices, MDOMF is priced at $16.00, while BDRFY trades at $16.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas BDRFY's P/E ratio is 16.42. In terms of profitability, MDOMF's ROE is +0.03%, compared to BDRFY's ROE of +0.11%. Regarding short-term risk, MDOMF is less volatile compared to BDRFY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check BDRFY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, BDRFF has a market cap of 17.8B. Regarding current trading prices, MDOMF is priced at $16.00, while BDRFF trades at $81.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas BDRFF's P/E ratio is 16.27. In terms of profitability, MDOMF's ROE is +0.03%, compared to BDRFF's ROE of +0.11%. Regarding short-term risk, MDOMF is less volatile compared to BDRFF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check BDRFF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, KAOOY has a market cap of 16.6B. Regarding current trading prices, MDOMF is priced at $16.00, while KAOOY trades at $7.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas KAOOY's P/E ratio is 24.47. In terms of profitability, MDOMF's ROE is +0.03%, compared to KAOOY's ROE of +0.12%. Regarding short-term risk, MDOMF is less volatile compared to KAOOY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check KAOOY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, KAOCF has a market cap of 15.9B. Regarding current trading prices, MDOMF is priced at $16.00, while KAOCF trades at $35.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas KAOCF's P/E ratio is 23.70. In terms of profitability, MDOMF's ROE is +0.03%, compared to KAOCF's ROE of +0.12%. Regarding short-term risk, MDOMF and KAOCF have similar daily volatility (0.00).Check KAOCF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, UNICY has a market cap of 10.4B. Regarding current trading prices, MDOMF is priced at $16.00, while UNICY trades at $3.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas UNICY's P/E ratio is 27.36. In terms of profitability, MDOMF's ROE is +0.03%, compared to UNICY's ROE of +0.08%. Regarding short-term risk, MDOMF is less volatile compared to UNICY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check UNICY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, UNCHF has a market cap of 10.1B. Regarding current trading prices, MDOMF is priced at $16.00, while UNCHF trades at $5.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas UNCHF's P/E ratio is 26.68. In terms of profitability, MDOMF's ROE is +0.03%, compared to UNCHF's ROE of +0.08%. Regarding short-term risk, MDOMF is less volatile compared to UNCHF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check UNCHF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, SSDOF has a market cap of 8.1B. Regarding current trading prices, MDOMF is priced at $16.00, while SSDOF trades at $20.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas SSDOF's P/E ratio is -31.23. In terms of profitability, MDOMF's ROE is +0.03%, compared to SSDOF's ROE of -0.07%. Regarding short-term risk, MDOMF is less volatile compared to SSDOF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check SSDOF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, SSDOY has a market cap of 7.9B. Regarding current trading prices, MDOMF is priced at $16.00, while SSDOY trades at $19.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas SSDOY's P/E ratio is -30.35. In terms of profitability, MDOMF's ROE is +0.03%, compared to SSDOY's ROE of -0.07%. Regarding short-term risk, MDOMF is less volatile compared to SSDOY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check SSDOY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, KCDMF has a market cap of 6.9B. Regarding current trading prices, MDOMF is priced at $16.00, while KCDMF trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas KCDMF's P/E ratio is 15.33. In terms of profitability, MDOMF's ROE is +0.03%, compared to KCDMF's ROE of +1.61%. Regarding short-term risk, MDOMF is less volatile compared to KCDMF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check KCDMF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, KCDMY has a market cap of 6.8B. Regarding current trading prices, MDOMF is priced at $16.00, while KCDMY trades at $11.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas KCDMY's P/E ratio is 15.14. In terms of profitability, MDOMF's ROE is +0.03%, compared to KCDMY's ROE of +1.61%. Regarding short-term risk, MDOMF is less volatile compared to KCDMY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check KCDMY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, LCCTF has a market cap of 6.6B. Regarding current trading prices, MDOMF is priced at $16.00, while LCCTF trades at $4.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas LCCTF's P/E ratio is 63.57. In terms of profitability, MDOMF's ROE is +0.03%, compared to LCCTF's ROE of +0.09%. Regarding short-term risk, MDOMF is less volatile compared to LCCTF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check LCCTF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, BICEY has a market cap of 5.6B. Regarding current trading prices, MDOMF is priced at $16.00, while BICEY trades at $33.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas BICEY's P/E ratio is 27.51. In terms of profitability, MDOMF's ROE is +0.03%, compared to BICEY's ROE of +0.05%. Regarding short-term risk, MDOMF is less volatile compared to BICEY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check BICEY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, HEGIY has a market cap of 3.9B. Regarding current trading prices, MDOMF is priced at $16.00, while HEGIY trades at $17.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas HEGIY's P/E ratio is 10.40. In terms of profitability, MDOMF's ROE is +0.03%, compared to HEGIY's ROE of +0.08%. Regarding short-term risk, MDOMF is less volatile compared to HEGIY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check HEGIY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, NTCOY has a market cap of 3.8B. Regarding current trading prices, MDOMF is priced at $16.00, while NTCOY trades at $5.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas NTCOY's P/E ratio is -8.30. In terms of profitability, MDOMF's ROE is +0.03%, compared to NTCOY's ROE of -0.15%. Regarding short-term risk, MDOMF is less volatile compared to NTCOY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check NTCOY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, UNLRF has a market cap of 3.8B. Regarding current trading prices, MDOMF is priced at $16.00, while UNLRF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas UNLRF's P/E ratio is 10.00. In terms of profitability, MDOMF's ROE is +0.03%, compared to UNLRF's ROE of +1.81%. Regarding short-term risk, MDOMF is less volatile compared to UNLRF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check UNLRF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, HEGIF has a market cap of 3.7B. Regarding current trading prices, MDOMF is priced at $16.00, while HEGIF trades at $3.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas HEGIF's P/E ratio is 11.03. In terms of profitability, MDOMF's ROE is +0.03%, compared to HEGIF's ROE of +0.12%. Regarding short-term risk, MDOMF and HEGIF have similar daily volatility (0.00).Check HEGIF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, UNLRY has a market cap of 3.7B. Regarding current trading prices, MDOMF is priced at $16.00, while UNLRY trades at $1.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas UNLRY's P/E ratio is 17.73. In terms of profitability, MDOMF's ROE is +0.03%, compared to UNLRY's ROE of +1.82%. Regarding short-term risk, MDOMF and UNLRY have similar daily volatility (0.00).Check UNLRY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, VDAHF has a market cap of 3.6B. Regarding current trading prices, MDOMF is priced at $16.00, while VDAHF trades at $2.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas VDAHF's P/E ratio is 99.00. In terms of profitability, MDOMF's ROE is +0.03%, compared to VDAHF's ROE of +0.02%. Regarding short-term risk, MDOMF and VDAHF have similar daily volatility (0.00).Check VDAHF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, RPHCF has a market cap of 3.4B. Regarding current trading prices, MDOMF is priced at $16.00, while RPHCF trades at $15.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas RPHCF's P/E ratio is 15.35. In terms of profitability, MDOMF's ROE is +0.03%, compared to RPHCF's ROE of +0.13%. Regarding short-term risk, MDOMF and RPHCF have similar daily volatility (0.00).Check RPHCF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, LIOPF has a market cap of 3.2B. Regarding current trading prices, MDOMF is priced at $16.00, while LIOPF trades at $11.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas LIOPF's P/E ratio is 17.98. In terms of profitability, MDOMF's ROE is +0.03%, compared to LIOPF's ROE of +0.09%. Regarding short-term risk, MDOMF and LIOPF have similar daily volatility (0.00).Check LIOPF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, VDAHY has a market cap of 3B. Regarding current trading prices, MDOMF is priced at $16.00, while VDAHY trades at $21.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas VDAHY's P/E ratio is 108.35. In terms of profitability, MDOMF's ROE is +0.03%, compared to VDAHY's ROE of +0.02%. Regarding short-term risk, MDOMF and VDAHY have similar daily volatility (0.00).Check VDAHY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, BICEF has a market cap of 2.8B. Regarding current trading prices, MDOMF is priced at $16.00, while BICEF trades at $68.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas BICEF's P/E ratio is 27.78. In terms of profitability, MDOMF's ROE is +0.03%, compared to BICEF's ROE of +0.05%. Regarding short-term risk, MDOMF and BICEF have similar daily volatility (0.00).Check BICEF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, KBYPF has a market cap of 2.5B. Regarding current trading prices, MDOMF is priced at $16.00, while KBYPF trades at $34.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas KBYPF's P/E ratio is 109.84. In terms of profitability, MDOMF's ROE is +0.03%, compared to KBYPF's ROE of +0.01%. Regarding short-term risk, MDOMF and KBYPF have similar daily volatility (0.00).Check KBYPF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, FACYF has a market cap of 2.4B. Regarding current trading prices, MDOMF is priced at $16.00, while FACYF trades at $17.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas FACYF's P/E ratio is 34.22. In terms of profitability, MDOMF's ROE is +0.03%, compared to FACYF's ROE of +0.22%. Regarding short-term risk, MDOMF and FACYF have similar daily volatility (0.00).Check FACYF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, LIOPY has a market cap of 2.3B. Regarding current trading prices, MDOMF is priced at $16.00, while LIOPY trades at $16.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas LIOPY's P/E ratio is 22.16. In terms of profitability, MDOMF's ROE is +0.03%, compared to LIOPY's ROE of +0.09%. Regarding short-term risk, MDOMF and LIOPY have similar daily volatility (0.00).Check LIOPY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, KSRYY has a market cap of 2.1B. Regarding current trading prices, MDOMF is priced at $16.00, while KSRYY trades at $7.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas KSRYY's P/E ratio is 21.57. In terms of profitability, MDOMF's ROE is +0.03%, compared to KSRYY's ROE of +0.05%. Regarding short-term risk, MDOMF is less volatile compared to KSRYY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check KSRYY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, BLUMY has a market cap of 2B. Regarding current trading prices, MDOMF is priced at $16.00, while BLUMY trades at $1.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas BLUMY's P/E ratio is -44.62. In terms of profitability, MDOMF's ROE is +0.03%, compared to BLUMY's ROE of -0.04%. Regarding short-term risk, MDOMF is less volatile compared to BLUMY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check BLUMY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, KOSCF has a market cap of 2B. Regarding current trading prices, MDOMF is priced at $16.00, while KOSCF trades at $34.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas KOSCF's P/E ratio is 20.42. In terms of profitability, MDOMF's ROE is +0.03%, compared to KOSCF's ROE of +0.04%. Regarding short-term risk, MDOMF is less volatile compared to KOSCF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check KOSCF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, PORBF has a market cap of 1.9B. Regarding current trading prices, MDOMF is priced at $16.00, while PORBF trades at $8.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas PORBF's P/E ratio is 45.79. In terms of profitability, MDOMF's ROE is +0.03%, compared to PORBF's ROE of +0.07%. Regarding short-term risk, MDOMF and PORBF have similar daily volatility (0.00).Check PORBF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, MIOFF has a market cap of 1.7B. Regarding current trading prices, MDOMF is priced at $16.00, while MIOFF trades at $52.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas MIOFF's P/E ratio is 40.46. In terms of profitability, MDOMF's ROE is +0.03%, compared to MIOFF's ROE of +0.04%. Regarding short-term risk, MDOMF and MIOFF have similar daily volatility (0.00).Check MIOFF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, PGENY has a market cap of 1.3B. Regarding current trading prices, MDOMF is priced at $16.00, while PGENY trades at $2.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas PGENY's P/E ratio is 25.27. In terms of profitability, MDOMF's ROE is +0.03%, compared to PGENY's ROE of +0.11%. Regarding short-term risk, MDOMF and PGENY have similar daily volatility (0.00).Check PGENY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, PIGEF has a market cap of 1.2B. Regarding current trading prices, MDOMF is priced at $16.00, while PIGEF trades at $10.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas PIGEF's P/E ratio is 22.43. In terms of profitability, MDOMF's ROE is +0.03%, compared to PIGEF's ROE of +0.11%. Regarding short-term risk, MDOMF is less volatile compared to PIGEF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check PIGEF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, SRTSF has a market cap of 1B. Regarding current trading prices, MDOMF is priced at $16.00, while SRTSF trades at $16.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas SRTSF's P/E ratio is 17.29. In terms of profitability, MDOMF's ROE is +0.03%, compared to SRTSF's ROE of +0.14%. Regarding short-term risk, MDOMF and SRTSF have similar daily volatility (0.00).Check SRTSF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, ONXYY has a market cap of 572.8M. Regarding current trading prices, MDOMF is priced at $16.00, while ONXYY trades at $1.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas ONXYY's P/E ratio is 14.92. In terms of profitability, MDOMF's ROE is +0.03%, compared to ONXYY's ROE of -0.18%. Regarding short-term risk, MDOMF is less volatile compared to ONXYY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check ONXYY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, DUNIY has a market cap of 471.4M. Regarding current trading prices, MDOMF is priced at $16.00, while DUNIY trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas DUNIY's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to DUNIY's ROE of +0.08%. Regarding short-term risk, MDOMF and DUNIY have similar daily volatility (0.00).Check DUNIY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, YAMNF has a market cap of 464.9M. Regarding current trading prices, MDOMF is priced at $16.00, while YAMNF trades at $8.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas YAMNF's P/E ratio is 8.37. In terms of profitability, MDOMF's ROE is +0.03%, compared to YAMNF's ROE of -0.02%. Regarding short-term risk, MDOMF and YAMNF have similar daily volatility (0.00).Check YAMNF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, ONXXF has a market cap of 413.2M. Regarding current trading prices, MDOMF is priced at $16.00, while ONXXF trades at $5.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas ONXXF's P/E ratio is 22.46. In terms of profitability, MDOMF's ROE is +0.03%, compared to ONXXF's ROE of -0.18%. Regarding short-term risk, MDOMF is less volatile compared to ONXXF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check ONXXF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, PZCUY has a market cap of 316.7M. Regarding current trading prices, MDOMF is priced at $16.00, while PZCUY trades at $1.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas PZCUY's P/E ratio is -37.75. In terms of profitability, MDOMF's ROE is +0.03%, compared to PZCUY's ROE of -0.02%. Regarding short-term risk, MDOMF is less volatile compared to PZCUY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check PZCUY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, MCBRF has a market cap of 315.4M. Regarding current trading prices, MDOMF is priced at $16.00, while MCBRF trades at $1.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas MCBRF's P/E ratio is 8.00. In terms of profitability, MDOMF's ROE is +0.03%, compared to MCBRF's ROE of +0.31%. Regarding short-term risk, MDOMF and MCBRF have similar daily volatility (0.00).Check MCBRF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, WPNTF has a market cap of 187.1M. Regarding current trading prices, MDOMF is priced at $16.00, while WPNTF trades at $2.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas WPNTF's P/E ratio is 9.65. In terms of profitability, MDOMF's ROE is +0.03%, compared to WPNTF's ROE of +0.19%. Regarding short-term risk, MDOMF is less volatile compared to WPNTF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check WPNTF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, OLVI has a market cap of 142.4M. Regarding current trading prices, MDOMF is priced at $16.00, while OLVI trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas OLVI's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to OLVI's ROE of -0.79%. Regarding short-term risk, MDOMF is less volatile compared to OLVI. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check OLVI's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, KITAF has a market cap of 135.3M. Regarding current trading prices, MDOMF is priced at $16.00, while KITAF trades at $0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas KITAF's P/E ratio is 19.41. In terms of profitability, MDOMF's ROE is +0.03%, compared to KITAF's ROE of +0.09%. Regarding short-term risk, MDOMF is less volatile compared to KITAF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check KITAF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, UNHLF has a market cap of 101.9M. Regarding current trading prices, MDOMF is priced at $16.00, while UNHLF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas UNHLF's P/E ratio is -4.30. In terms of profitability, MDOMF's ROE is +0.03%, compared to UNHLF's ROE of -0.11%. Regarding short-term risk, MDOMF and UNHLF have similar daily volatility (0.00).Check UNHLF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, NBBTF has a market cap of 100.1M. Regarding current trading prices, MDOMF is priced at $16.00, while NBBTF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas NBBTF's P/E ratio is -5.00. In terms of profitability, MDOMF's ROE is +0.03%, compared to NBBTF's ROE of +0.02%. Regarding short-term risk, MDOMF and NBBTF have similar daily volatility (0.00).Check NBBTF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, KPTSF has a market cap of 83.6M. Regarding current trading prices, MDOMF is priced at $16.00, while KPTSF trades at $8.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas KPTSF's P/E ratio is 13.47. In terms of profitability, MDOMF's ROE is +0.03%, compared to KPTSF's ROE of +0.06%. Regarding short-term risk, MDOMF is less volatile compared to KPTSF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check KPTSF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, RVIV has a market cap of 79M. Regarding current trading prices, MDOMF is priced at $16.00, while RVIV trades at $13.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas RVIV's P/E ratio is 64.29. In terms of profitability, MDOMF's ROE is +0.03%, compared to RVIV's ROE of -0.02%. Regarding short-term risk, MDOMF is less volatile compared to RVIV. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check RVIV's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, ZOONF has a market cap of 17.7M. Regarding current trading prices, MDOMF is priced at $16.00, while ZOONF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas ZOONF's P/E ratio is -4.36. In terms of profitability, MDOMF's ROE is +0.03%, compared to ZOONF's ROE of -0.98%. Regarding short-term risk, MDOMF is less volatile compared to ZOONF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check ZOONF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, ADTI has a market cap of 10.1M. Regarding current trading prices, MDOMF is priced at $16.00, while ADTI trades at $1.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas ADTI's P/E ratio is -1.15. In terms of profitability, MDOMF's ROE is +0.03%, compared to ADTI's ROE of +0.72%. Regarding short-term risk, MDOMF is less volatile compared to ADTI. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check ADTI's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, DQWS has a market cap of 8.7M. Regarding current trading prices, MDOMF is priced at $16.00, while DQWS trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas DQWS's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to DQWS's ROE of -0.51%. Regarding short-term risk, MDOMF is less volatile compared to DQWS. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check DQWS's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, PURE has a market cap of 7.2M. Regarding current trading prices, MDOMF is priced at $16.00, while PURE trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas PURE's P/E ratio is -3.20. In terms of profitability, MDOMF's ROE is +0.03%, compared to PURE's ROE of +0.40%. Regarding short-term risk, MDOMF is less volatile compared to PURE. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check PURE's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, MIMNF has a market cap of 6.8M. Regarding current trading prices, MDOMF is priced at $16.00, while MIMNF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas MIMNF's P/E ratio is 17.10. In terms of profitability, MDOMF's ROE is +0.03%, compared to MIMNF's ROE of N/A. Regarding short-term risk, MDOMF and MIMNF have similar daily volatility (0.00).Check MIMNF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, PRFUF has a market cap of 5.5M. Regarding current trading prices, MDOMF is priced at $16.00, while PRFUF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas PRFUF's P/E ratio is -0.25. In terms of profitability, MDOMF's ROE is +0.03%, compared to PRFUF's ROE of -0.04%. Regarding short-term risk, MDOMF is less volatile compared to PRFUF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check PRFUF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, MAVBF has a market cap of 4.8M. Regarding current trading prices, MDOMF is priced at $16.00, while MAVBF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas MAVBF's P/E ratio is -0.03. In terms of profitability, MDOMF's ROE is +0.03%, compared to MAVBF's ROE of -2.47%. Regarding short-term risk, MDOMF and MAVBF have similar daily volatility (0.00).Check MAVBF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, REVRQ has a market cap of 3.8M. Regarding current trading prices, MDOMF is priced at $16.00, while REVRQ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas REVRQ's P/E ratio is -0.01. In terms of profitability, MDOMF's ROE is +0.03%, compared to REVRQ's ROE of +0.29%. Regarding short-term risk, MDOMF and REVRQ have similar daily volatility (0.00).Check REVRQ's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, NASO has a market cap of 3.6M. Regarding current trading prices, MDOMF is priced at $16.00, while NASO trades at $1.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas NASO's P/E ratio is -2.39. In terms of profitability, MDOMF's ROE is +0.03%, compared to NASO's ROE of +0.53%. Regarding short-term risk, MDOMF is less volatile compared to NASO. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check NASO's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, CLGOF has a market cap of 3.6M. Regarding current trading prices, MDOMF is priced at $16.00, while CLGOF trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas CLGOF's P/E ratio is -2.65. In terms of profitability, MDOMF's ROE is +0.03%, compared to CLGOF's ROE of +1.43%. Regarding short-term risk, MDOMF is less volatile compared to CLGOF. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check CLGOF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, CAWW has a market cap of 3.6M. Regarding current trading prices, MDOMF is priced at $16.00, while CAWW trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas CAWW's P/E ratio is 23.50. In terms of profitability, MDOMF's ROE is +0.03%, compared to CAWW's ROE of +0.03%. Regarding short-term risk, MDOMF is less volatile compared to CAWW. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check CAWW's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, SNBH has a market cap of 2.3M. Regarding current trading prices, MDOMF is priced at $16.00, while SNBH trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas SNBH's P/E ratio is -1.74. In terms of profitability, MDOMF's ROE is +0.03%, compared to SNBH's ROE of +0.75%. Regarding short-term risk, MDOMF is less volatile compared to SNBH. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check SNBH's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, NUVI has a market cap of 1.8M. Regarding current trading prices, MDOMF is priced at $16.00, while NUVI trades at $4.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas NUVI's P/E ratio is 33.33. In terms of profitability, MDOMF's ROE is +0.03%, compared to NUVI's ROE of +0.01%. Regarding short-term risk, MDOMF is less volatile compared to NUVI. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check NUVI's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, SKVI has a market cap of 1M. Regarding current trading prices, MDOMF is priced at $16.00, while SKVI trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas SKVI's P/E ratio is -0.96. In terms of profitability, MDOMF's ROE is +0.03%, compared to SKVI's ROE of +0.00%. Regarding short-term risk, MDOMF is less volatile compared to SKVI. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check SKVI's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, SLGD has a market cap of 812.9K. Regarding current trading prices, MDOMF is priced at $16.00, while SLGD trades at $1.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas SLGD's P/E ratio is -0.19. In terms of profitability, MDOMF's ROE is +0.03%, compared to SLGD's ROE of -0.11%. Regarding short-term risk, MDOMF is less volatile compared to SLGD. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check SLGD's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, SPCO has a market cap of 777K. Regarding current trading prices, MDOMF is priced at $16.00, while SPCO trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas SPCO's P/E ratio is -19.19. In terms of profitability, MDOMF's ROE is +0.03%, compared to SPCO's ROE of -0.01%. Regarding short-term risk, MDOMF is less volatile compared to SPCO. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check SPCO's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, WNBD has a market cap of 732.9K. Regarding current trading prices, MDOMF is priced at $16.00, while WNBD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas WNBD's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to WNBD's ROE of +0.01%. Regarding short-term risk, MDOMF and WNBD have similar daily volatility (0.00).Check WNBD's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, PYCT has a market cap of 553.7K. Regarding current trading prices, MDOMF is priced at $16.00, while PYCT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas PYCT's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to PYCT's ROE of +0.64%. Regarding short-term risk, MDOMF and PYCT have similar daily volatility (0.00).Check PYCT's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, PHLI has a market cap of 438.3K. Regarding current trading prices, MDOMF is priced at $16.00, while PHLI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas PHLI's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to PHLI's ROE of -0.54%. Regarding short-term risk, MDOMF is less volatile compared to PHLI. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check PHLI's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, SNST has a market cap of 265.9K. Regarding current trading prices, MDOMF is priced at $16.00, while SNST trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas SNST's P/E ratio is -0.03. In terms of profitability, MDOMF's ROE is +0.03%, compared to SNST's ROE of -1.59%. Regarding short-term risk, MDOMF is less volatile compared to SNST. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check SNST's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, HRSR has a market cap of 177.6K. Regarding current trading prices, MDOMF is priced at $16.00, while HRSR trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas HRSR's P/E ratio is -0.02. In terms of profitability, MDOMF's ROE is +0.03%, compared to HRSR's ROE of +65.69%. Regarding short-term risk, MDOMF is less volatile compared to HRSR. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check HRSR's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, NUUU has a market cap of 117.8K. Regarding current trading prices, MDOMF is priced at $16.00, while NUUU trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas NUUU's P/E ratio is -0.01. In terms of profitability, MDOMF's ROE is +0.03%, compared to NUUU's ROE of +0.36%. Regarding short-term risk, MDOMF and NUUU have similar daily volatility (0.00).Check NUUU's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, EESO has a market cap of 72.9K. Regarding current trading prices, MDOMF is priced at $16.00, while EESO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas EESO's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to EESO's ROE of N/A. Regarding short-term risk, MDOMF is less volatile compared to EESO. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check EESO's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, TVOG has a market cap of 63.9K. Regarding current trading prices, MDOMF is priced at $16.00, while TVOG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas TVOG's P/E ratio is -0.03. In terms of profitability, MDOMF's ROE is +0.03%, compared to TVOG's ROE of +0.78%. Regarding short-term risk, MDOMF and TVOG have similar daily volatility (0.00).Check TVOG's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, EOSS has a market cap of 60.5K. Regarding current trading prices, MDOMF is priced at $16.00, while EOSS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas EOSS's P/E ratio is -0.01. In terms of profitability, MDOMF's ROE is +0.03%, compared to EOSS's ROE of +0.64%. Regarding short-term risk, MDOMF is less volatile compared to EOSS. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check EOSS's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, QNTA has a market cap of 40.7K. Regarding current trading prices, MDOMF is priced at $16.00, while QNTA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas QNTA's P/E ratio is 0.01. In terms of profitability, MDOMF's ROE is +0.03%, compared to QNTA's ROE of +2.75%. Regarding short-term risk, MDOMF and QNTA have similar daily volatility (0.00).Check QNTA's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, SYHO has a market cap of 39.6K. Regarding current trading prices, MDOMF is priced at $16.00, while SYHO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas SYHO's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to SYHO's ROE of N/A. Regarding short-term risk, MDOMF and SYHO have similar daily volatility (0.00).Check SYHO's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, GRBG has a market cap of 39K. Regarding current trading prices, MDOMF is priced at $16.00, while GRBG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas GRBG's P/E ratio is 0.10. In terms of profitability, MDOMF's ROE is +0.03%, compared to GRBG's ROE of N/A. Regarding short-term risk, MDOMF and GRBG have similar daily volatility (0.00).Check GRBG's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, JOEY has a market cap of 37.7K. Regarding current trading prices, MDOMF is priced at $16.00, while JOEY trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas JOEY's P/E ratio is 0.01. In terms of profitability, MDOMF's ROE is +0.03%, compared to JOEY's ROE of +0.19%. Regarding short-term risk, MDOMF is less volatile compared to JOEY. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check JOEY's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, EMPO has a market cap of 25.1K. Regarding current trading prices, MDOMF is priced at $16.00, while EMPO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas EMPO's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to EMPO's ROE of -0.37%. Regarding short-term risk, MDOMF is less volatile compared to EMPO. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check EMPO's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, HPTN has a market cap of 22.7K. Regarding current trading prices, MDOMF is priced at $16.00, while HPTN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas HPTN's P/E ratio is -0.04. In terms of profitability, MDOMF's ROE is +0.03%, compared to HPTN's ROE of -1.08%. Regarding short-term risk, MDOMF is less volatile compared to HPTN. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check HPTN's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, INBI has a market cap of 18.1K. Regarding current trading prices, MDOMF is priced at $16.00, while INBI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas INBI's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to INBI's ROE of +0.54%. Regarding short-term risk, MDOMF is less volatile compared to INBI. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check INBI's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, GYSN has a market cap of 14K. Regarding current trading prices, MDOMF is priced at $16.00, while GYSN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas GYSN's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to GYSN's ROE of +0.14%. Regarding short-term risk, MDOMF and GYSN have similar daily volatility (0.00).Check GYSN's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, KPOC has a market cap of 13.7K. Regarding current trading prices, MDOMF is priced at $16.00, while KPOC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas KPOC's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to KPOC's ROE of +0.01%. Regarding short-term risk, MDOMF and KPOC have similar daily volatility (0.00).Check KPOC's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, ZRVT has a market cap of 13K. Regarding current trading prices, MDOMF is priced at $16.00, while ZRVT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas ZRVT's P/E ratio is -0.02. In terms of profitability, MDOMF's ROE is +0.03%, compared to ZRVT's ROE of +0.04%. Regarding short-term risk, MDOMF and ZRVT have similar daily volatility (0.00).Check ZRVT's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, BRSHF has a market cap of 6.7K. Regarding current trading prices, MDOMF is priced at $16.00, while BRSHF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas BRSHF's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to BRSHF's ROE of +14.14%. Regarding short-term risk, MDOMF and BRSHF have similar daily volatility (0.00).Check BRSHF's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, BEUT has a market cap of 3.2K. Regarding current trading prices, MDOMF is priced at $16.00, while BEUT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas BEUT's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to BEUT's ROE of +1.96%. Regarding short-term risk, MDOMF and BEUT have similar daily volatility (0.00).Check BEUT's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, MDAV has a market cap of 2.8K. Regarding current trading prices, MDOMF is priced at $16.00, while MDAV trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas MDAV's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to MDAV's ROE of -1.64%. Regarding short-term risk, MDOMF is less volatile compared to MDAV. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check MDAV's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, NCDP has a market cap of 1.8K. Regarding current trading prices, MDOMF is priced at $16.00, while NCDP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas NCDP's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to NCDP's ROE of N/A. Regarding short-term risk, MDOMF is less volatile compared to NCDP. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check NCDP's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, RBCL has a market cap of 1.5K. Regarding current trading prices, MDOMF is priced at $16.00, while RBCL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas RBCL's P/E ratio is -0.03. In terms of profitability, MDOMF's ROE is +0.03%, compared to RBCL's ROE of -0.10%. Regarding short-term risk, MDOMF is less volatile compared to RBCL. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check RBCL's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, BMXC has a market cap of 916. Regarding current trading prices, MDOMF is priced at $16.00, while BMXC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas BMXC's P/E ratio is -0.02. In terms of profitability, MDOMF's ROE is +0.03%, compared to BMXC's ROE of +1.17%. Regarding short-term risk, MDOMF is less volatile compared to BMXC. This indicates potentially lower risk in terms of short-term price fluctuations for MDOMF.Check BMXC's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, PCGR has a market cap of 785. Regarding current trading prices, MDOMF is priced at $16.00, while PCGR trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas PCGR's P/E ratio is -0.01. In terms of profitability, MDOMF's ROE is +0.03%, compared to PCGR's ROE of -0.18%. Regarding short-term risk, MDOMF and PCGR have similar daily volatility (0.00).Check PCGR's competition here

MDOMF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDOMF stands at 722.2M. In comparison, SOYO has a market cap of 62. Regarding current trading prices, MDOMF is priced at $16.00, while SOYO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDOMF currently has a P/E ratio of 57.14, whereas SOYO's P/E ratio is N/A. In terms of profitability, MDOMF's ROE is +0.03%, compared to SOYO's ROE of N/A. Regarding short-term risk, MDOMF and SOYO have similar daily volatility (0.00).Check SOYO's competition here